Diego A. Díaz-García, Medical Oncologist /CEO/Founder at CánCare – High Specialty in Oncology, shared on X:
“Agonistic antibody immunotherapy.
Agonistic antibodies activate immune receptors to enhance antitumor immunity.
Improved understanding of receptor signaling and antibody engineering is paving the way for safer and more effective therapies.”
Title: Realizing the potential of agonistic antibody immunotherapy
Authors: Mark S. Cragg, Xiaojie Yu, Christopher Paluch, Simon J. Davis
Read The Full Article.
